Provexis Showcases Strong Revenue Growth and Partnerships

Provexis (GB:PXS) has released an update.

Provexis PLC reported significant growth with a 106% increase in total revenue for the fiscal year ending March 31, 2024, driven by strong sales and interest in its Fruitflow II SD ingredient. The company has transitioned to direct sales, with substantial progress in the Chinese market, and an expanding sales pipeline through a partnership with DSM. Despite revenue growth, the company recorded an underlying operating loss and a decrease in cash reserves.

For further insights into GB:PXS stock, check out TipRanks’ Stock Analysis page.